Gene Yaw (R-23) is joined by Guthrie Robert Packer Hospital President and Chief Executive Officer Dr. This year, 12 projects were selected from 82 entries.įor more state-related news and information, constituents can visit Senator Yaw’s website at or follow him on Facebook and Twitter caption: Sen. HAP’s annual Achievement Awards program recognizes hospitals and health systems that are employing innovative approaches to strengthening the safety and quality of care, enhancing operations and patients’ experience, and partnering with their communities to address public health needs. “Staff and administrators there are setting the standard for innovative approaches to patient-focused care and safety, and I am pleased to see their dedication and tireless work recognized.”
“Despite unprecedented challenges faced by rural health systems in recent years, Guthrie Robert Packer Hospital continues to exceed expectations,” said Sen.
The In Safe Hands Award for implementing new procedures to reduce hospital-acquired infections.The Optimal Operations Award for implementing a new team-based approach to nursing to reduce staff turnover and vacancies, improve patient and staff satisfaction, and improve quality.Yaw joined hospital staff and leaders as they received two Achievement Awards: Packer for his substantial contributions to pediatric oncology and scientific achievements.HARRISBURG – Guthrie Robert Packer Hospital in Sayre, Bradford County, was honored during the 2023 Hospital and Healthsystem Association of Pennsylvania (HAP) annual Leadership Summit in Harrisburg last week, according to Sen. In 2020 the International Symposium on Pediatric Neuro-Oncology bestowed its Lifetime Achievement Award on Dr. He has published over 400 original articles and 350 reviews and chapters. Packer are studies evaluating innovative agents aimed at the molecular underpinnings of neurologic disease. The majority of the studies now being coordinated by Dr. He has been part of studies evaluating the molecular genetics of childhood and adult neurologic diseases and also has coordinated the first gene therapy study for children with malignant brain tumors in the U.S. Packer’s clinical research has been translational in nature. He is presently co-chair of the Brain Malignancy Committee of the NCI. He headed the efforts in pediatrics for the program review, held by the NCI and NINDS for brain tumors. He has worked closely with the NCI and the National Institute of Neurological Disorders and Stroke (NINDS), and has served on multiple committees setting the directions for neurologic clinical and basic science research for the future. Packer is principal investigator (PI) at Children’s National for the Pediatric Brain Tumor Consortium (PBTC), formed under the auspices of the National Cancer Institute (NCI) chair of the PBTC Low-Grade Glioma Committee site PI for Children's National for the Neurofibromatosis Clinical Trials Consortium and chair of the Medulloblastoma Committee of the Children’s Oncology Group. Many of the clinical trials in neurofibromatosis and brain tumors are translational, bringing advances from the bench to the bedside expeditiously. Much of his research has focused on the development and performance of clinical trials for adults and children with neurologic, neuro-oncologic and neurogenetic disorders, and he has received peer-reviewed grant support for this research. His clinical research has touched on various aspects of adult and child neurology and neuro-oncology, including adult and pediatric brain tumors, neurofibromatosis type 1, the neurologic aspects of childhood neurogenetic diseases, and multiple other topics in general child neurology. Packer has been heavily involved in clinical and applied basic science research. Packer was director of the Brain Tumor Program and professor of Neurology and Pediatrics at the Children’s Hospital of Philadelphia, University of Pennsylvania. Prior to coming to Children’s National, Dr. They are affiliated with medical facilities Guthrie Corning Hospital and Guthrie Robert Packer Hospital. They graduated from PENNSYLVANIA STATE UNIVERSITY / COLLEGE OF MEDICINE in 1986. He holds the Gilbert Family Distinguished Professorship in Neurofibromatosis. Robert Fanelli, MD is a general surgery specialist in Horseheads, NY and has over 36 years of experience in the medical field. Packer’s present academic titles include professor of Neurology and Pediatrics at George Washington University and clinical professor of Neurosurgery at the University of Virginia in Charlottesville, Virginia. Packer, M.D., is the Gilbert Distinguished Professor of Neurofibromatosis, and is director of both the Gilbert Neurofibromatosis Institute and the Brain Tumor Institute of Children’s National Hospital.
0 kommentar(er)
